Protein Linking Diabetes & Non-Alcoholic Fatty Liver Disease Found

Fetuin B, which is present in high levels in non-alcoholic fatty liver disease patients, impairs the action of insulin in the body.

AsianScientist (Nov. 6, 2015) – Monash researchers have discovered a protein, called Fetuin B, which is present in high levels in patients with non-alcoholic fatty liver disease (NAFLD). Importantly, the protein has been shown to impair the actions of insulin, providing an explanation (and potential therapeutic target) as a major cause of diabetes. The research has just been published in the journal, Cell Metabolism.

The Western world is getting fatter and this has resulted in the development of a relatively new disease called NAFLD, which is present in around 60 percent of obese adults. The disease, which puts the person at very high risk of developing diabetes, is also on the increase in Asian countries, where a prevalence of 15 percent has been reported.

Researchers at Monash’s Biomedicine Discovery Institute, led by Professor Matthew Watt, have discovered a novel protein that is released as a consequence of fatty liver and causes pre-diabetes. The discovery of this new protein opens the way to developing drugs that can block the production of this protein potentially preventing the disease.

Originally discovered in mice prone to diabetes, the protein called Fetuin B, has been shown to be in high levels in patients with Type 2 diabetes. Patients in the trial–in the Netherlands and in Melbourne–were found to have high levels of the protein only if they were also pre-diabetic or diabetic. Volunteers who were tested who were obese (but not diabetic) did not have high levels of Fetuin B.

According to Watt, the Fetuin B protein provides a clear and causal link between the development of NAFLD and the development of Type 2 diabetes.

“By developing a drug that could block this protein, it may be possible to prevent the development of diabetes in patients with fatty liver,” Watt said.

The article can be found at: Meex et al. (2015) Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism.


Source: Monash University.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist